重组Anti-AKT2抗体[EP1676]
Anti-AKT2 antibody [EP1676]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- 了解详情
Be the first to review this product! Submit a review
|
(14 Publications)
Rabbit Recombinant Monoclonal AKT2 antibody. Suitable for WB and reacts with Human, Mouse, Rat samples. Cited in 14 publications.
查看别名
RAC-beta serine/threonine-protein kinase, Protein kinase Akt-2, Protein kinase B beta, RAC protein kinase beta, PKB beta, RAC-PK-beta, AKT2
- WB
Lab
Western blot - Anti-AKT2 antibody [EP1676] (AB131168)
Western blot : Anti-AKT2 antibody [EP1676] ab131168 staining at 1/5000 dilution, shown in green; Mouse anti GAPDH ab8245 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 56 kDa in Wild-type MCF7 cell lysates with no signal observed at this size in AKT2 knockout MCF7 cell line. This antibody also detects AKT1; gel running protocol should be optimised to separate these bands. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween 20 (TBS-T) before incubation with primary antibodies overnight at 4 C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-AKT2 antibody [EP1676] (ab131168) at 1/5000 dilution
Lane 1:
Wild-type MCF7 at 20 µg
Lane 2:
Western blot - Human AKT2 knockout MCF7 cell line (ab286253) at 20 µg
Lane 3:
A549 at 20 µg
Lane 4:
THP-1 at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 56 kDa
Observed band size: 56 kDa
false
- WB
Supplier Data
Western blot - Anti-AKT2 antibody [EP1676] (AB131168)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-AKT2 antibody [EP1676] (ab131168) at 1/5000 dilution
Lane 1:
Jurkat (Human T cell leukemia T lymphocyte) whole cell lysate at 20 µg
Lane 2:
JAR (Human placenta choriocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
NIH/3T3 (Mouse embryonic fibroblast) whole cell lysate at 20 µg
Lane 4:
C6 (Rat glial tumor glial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 60 kDa
false
Exposure time: 60s
不同偶联物与剂型 (1)
-
Anti-AKT2 antibody [EP1676] - BSA and Azide free
反应性数据
产品详情
This product has switched from a hybridoma to recombinant production method on 9th February 2024.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The protein engages in controlling glucose transport and metabolism. As part of its biological functions AKT2 becomes phosphorylated and activated in response to insulin signaling and does not work as a part of a larger complex but interacts with other proteins. It plays a significant role in maintaining normal insulin sensitivity in tissues by facilitating the uptake and storage of glucose. Additionally the protein influences cell cycle progression and can affect apoptotic responses contributing to processes like protein synthesis and cell proliferation.
Pathways
AKT2 involves signaling mechanisms that include the PI3K/AKT/mTOR pathway and the insulin signaling pathway. These pathways are deeply connected to cellular growth and metabolic regulation. AKT2 works closely with proteins such as PI3K which phosphorylates phosphoinositides and mTOR that control protein synthesis by activating downstream targets. These interactions highlight the integration of AKT2 in nutrient-sensing pathways and how it aids the regulation of energy status in response to external stimuli.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (14)
Recent publications for all applications. Explore the full list and refine your search
Journal of inflammation research 18:13575-13592 PubMed41054626
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine (Cambridge, Mass.) 30:239 PubMed39616329
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:9100 PubMed38643275
2024
Applications
Unspecified application
Species
Unspecified reactive species
General physiology and biophysics 43:175-183 PubMed38477607
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of orthopaedic surgery and research 18:646 PubMed37653390
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell and tissue research 393:455-470 PubMed37450039
2023
Applications
Unspecified application
Species
Unspecified reactive species
Open life sciences 18:20220588 PubMed37077346
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer gene therapy 30:582-595 PubMed36854894
2023
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 11: PubMed36831001
2023
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 12:11909-11921 PubMed34802381
2021
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com